logo
Plus   Neg
Share
Email

Roche Announces First Approval For Tecentriq-based Therapy In China

Roche (RHHBY) said the China National Medical Products Administration has approved Tecentriq in combination with chemotherapy for the first-line treatment of patients with extensive-stage small cell lung cancer. The company noted that approval in China comes less than a year after the FDA and EMA approvals in the indication.

In January 2020, the China National Medical Products Administration also accepted the supplemental Biologics License Application for Tecentriq in combination with Avastin for the treatment of people with unresectable hepatocellular carcinoma.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>